Skip to main content

GOLDMAN SACHS GROUP INC

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in PLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,108,897
+$563,479 QoQ
Shares Held
475,922
+89.4% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 101 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. PLX ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PLX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,108,897 475,922
2026-03-31 $545,418 251,345
2025-12-31 $473,056 262,809
2025-09-30 $334,839 150,829
2025-06-30 $151,222 102,178
2025-03-31 $741,020 289,461
2024-12-31 $93,454 49,710
2024-09-30 $51,245 50,241
2024-06-30 $540,490 461,958
2024-03-31 $116,453 92,424
2023-12-31 $185,966 104,476
2023-09-30 $178,939 107,795
2023-06-30 $100,388 50,194